ArticleDrug design, development and therapy2020

Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination.

Chengjiang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.